| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 537.77 mm | 537.77 mm | 537.77 mm | 537.77 mm | 537.77 mm | |
| Cash burn (monthly) | (no burn) | (no burn) | 2.83 mm | 6.39 mm | 382.25 k | |
| Cash used (since last report) | n/a | n/a | 11.40 mm | 25.71 mm | 1.54 mm | |
| Cash remaining | n/a | n/a | 526.36 mm | 512.06 mm | 536.23 mm | |
| Runway (months of cash) | n/a | n/a | 185.7 | 80.2 | 1402.8 | |
| 13F holders | Current |
|---|---|
| Total holders | 128 |
| Opened positions | 18 |
| Closed positions | 29 |
| Increased positions | 47 |
| Reduced positions | 35 |
| 13F shares | Current |
|---|---|
| Total value | 1.12 tn |
| Total shares | 47.36 mm |
| Total puts | 450.90 k |
| Total calls | 192.40 k |
| Total put/call ratio | 2.3 |
| Largest owners | Shares | Value |
|---|---|---|
| Wellington Management | 7.05 mm | $219.43 bn |
| T. Rowe Price Investment Management | 6.50 mm | $202.34 mm |
| RTW Investments | 4.87 mm | $151.60 bn |
| FMR | 4.84 mm | $150.55 bn |
| Primecap Management | 2.47 mm | $76.95 bn |
| T. Rowe Price | 2.16 mm | $67.17 mm |
| Malin Life Sciences | 2.11 mm | $111.40 mm |
| Baker Bros. Advisors | 1.52 mm | $47.17 bn |
| Armistice Capital | 1.26 mm | $39.35 bn |
| General Atlantic | 1.26 mm | $39.28 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Jan 25 | Travis Alan Coy | Employee Share Option Ordinary Shares | Grant | Acquire A | No | No | 29.5 | 274,033 | 8.08 mm | 274,033 |
| 28 May 24 | Baker Bros. Advisors | Non-Qualified Share Option Ordinary Shares | Grant | Acquire A | Yes | No | 46.05 | 12,925 | 595.20 k | 12,925 |
| 28 May 24 | Baker Bros. Advisors | Non-Qualified Share Option Ordinary Shares | Grant | Acquire A | Yes | No | 46.05 | 12,925 | 595.20 k | 12,925 |
| 23 May 24 | John Irving Bell | Share Option Ordinary Shares | Grant | Acquire A | No | No | 50.47 | 14,534 | 733.53 k | 14,534 |
